Company

MTHERA PHARMA

MTHERA PHARMA researches and develops drug candidates for chronic and other diseases.

About

Founded in 2020 and based in Seoul, MTHERA PHARMA researches, develops, and commercializes pharmaceutical products for oncology, neurological, cardiovascular, and rare disorders. Its pipeline includes candidates for Parkinson’s disease, inflammatory bowel diseases, diabetic neuropathy, Alzheimer’s disease, viral conditions, and cancer. In April 2021, it raised KRW 3.2 billion in Series A funding from Tony Investment, Sejong Venture Partners, and DAYLI Partners.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in